COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Hospital converts main entrance into COVID x-ray room

Possibly setting a precedent that could be followed in many U.S. hospitals, a medical center in Reading, Pennsylvania, has set up a curbside radiography service specifically for COVID-positive and -suspected patients.

Thumbnail

South Dakota, Hawaii bookend states with fewest, most COVID constraints

Compared with the Aloha State, the Mount Rushmore State is a practical free-for-all during the COVID-19 crisis.

Thumbnail

Almost 80% of US nurses worry about infecting loved ones with COVID-19

A national sampling of more than 15,000 nurses is collectively reporting “infecting family and friends” as the profession’s single most pressing concern during the COVID-19 crisis.

Thumbnail

A potential risk: New studies highlight the connection between treating COVID-19 with hydroxychloroquine and QTc prolongation

Treating COVID-19 patients with hydroxychloroquine, alone or in combination with azithromycin, is associated with an increased risk of QTc prolongation, according to two new studies published in JAMA Cardiology.

Thumbnail

Cardiovascular groups share joint guidance on continuation of procedures, diagnostic tests during COVID-19 pandemic

A group of cardiovascular societies, including the American College of Cardiology (ACC) and American Heart Association (AHA), has published a new guidance designed to help providers resume important procedures and diagnostic tests during the COVID-19 pandemic.

Thumbnail

American Heart Association dedicates another $2M to COVID-19 research

“We were just blown away and so impressed to see this level of interest and commitment from the teams submitting such thorough proposals so quickly,” said AHA President Robert A. Harrington, MD.

Thumbnail

Novartis launches FDA-approved study involving hydroxychloroquine, azithromycin, COVID-19 patients

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine.

Thumbnail

What high COVID-19 mortality among black patients tells us about CVD care in the US

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.